| 000 | 01915nam a2200241 4500 | ||
|---|---|---|---|
| 003 | NALT | ||
| 005 | 20251224113502.0 | ||
| 008 | 251105b th ||||| |||| 00| 0 eng d | ||
| 040 | _aNALT | ||
| 050 |
_aQR 189.5.R3 _bA64D 2023 |
||
| 100 | 0 |
_aApidsada Chorpunkul. _966885 |
|
| 245 | 1 | 0 |
_aThe development of therapeutic monoclonal antibodies against rabies virus from immunized phage-displayed libraries / _cApidsada Chorpunkul. |
| 260 |
_aNakhonpathom : _bMahidol University, _c2023. |
||
| 300 |
_a276 p. : _bill., tables, chart ; _c30 cm. |
||
| 505 | 2 | _aChapter 1 Introduction and objectives -- Chapter 2 Literature reviews -- Chapter 3 Materials and methods -- 3.1 Sample collection and Preparation -- 3.2 Plasma RFFIT assay and PBMC isolation -- 3.3 Total RNA extraction and cDNA synthesis -- 3.4 Variable heavy (VH) and light chain (VL, kappa and lambda) fragment amplification -- 3.5 Generation of single chain variable fragments (scFv) -- 3.6 Construction of scFv libraries -- 3.7 The scFv phage display library construction -- 3.8 Biopanning (Affinity selection) -- 3.9 Specific binding ELISA of individual clones -- 3.10 DNA sequencing and CDR determination -- 3.11 Soluble scFv expression -- 3.12 Purification of soluble scFv antibodies -- 3.13 Modified Rapid Fluorescent Foci Inhibition Test (RFFIT): neutralization assay -- 3.14 Sensitivity test and binding ability of neutralizing scFv clones by dot-blot ELISA -- 3.15 Bioinformatics -- Chapter 4 Results -- 4.1 Human therapeutic monoclonal antibodies against RABV -- 4.2 Caine therapeutic monoclonal antibodies against RABV -- Chapter 5 Discussion -- Chapter 6 Conclusion. | |
| 650 | 0 |
_aRabies _966905 |
|
| 650 | 0 |
_aRabies virus _966904 |
|
| 942 |
_2lcc _cRSH |
||
| 996 |
_ajidapa.t _bACQSTF _c2025-11-05 |
||
| 996 |
_avaree.k _bLIBSTF _c2025-11-06 |
||
| 996 |
_ajamriang.p _bCATSTF _c2025-11-06 |
||
| 999 |
_c107428 _d107428 |
||
| 998 |
_j1020 _k นางจำเรียง ระวังสำโรง |
||